Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Patrick ImfeldChristoph R Meier

Abstract

Long-term use of proton pump inhibitors (PPIs) has been associated with an increased risk of Alzheimer's disease (AD) in observational studies. The role of exposure duration, and whether this applies to other dementia subtypes, has not been explored in these studies. The aim was to study the association between long-term use of PPIs (or of histamine-2 receptor antagonists [H2RAs], as a negative control) and the risk of developing AD or vascular dementia (VaD). We conducted a case-control analysis on the UK-based Clinical Practice Research Datalink (CPRD). We identified 41,029 patients aged ≥ 65 years with newly diagnosed AD or VaD between 1998 and 2015 and matched them 1:1 to dementia-free controls on age, sex, calendar time, general practice, and number of years of recorded history. We applied conditional logistic regression analyses to calculate adjusted odds ratios (aORs), with 95% confidence intervals (CIs), of developing AD or VaD in relation to previous use of PPIs or H2RAs, categorized by exposure duration. As compared to non-use, long-term PPI use (≥ 100 prescriptions) was not associated with an increased risk of developing AD (aOR 0.88, 95% CI 0.80-0.97) or VaD (aOR 1.18, 95% CI 1.04-1.33). Neither was long-term use of...Continue Reading

References

Feb 1, 1980·The American Journal of Medicine·R I Horwitz, A R Feinstein
Nov 23, 2000·Lancet·H JickD A Drachman
Mar 20, 2001·Archives of Neurology·S SeshadriD A Drachman
Mar 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Tim StevensCornelius Katona
May 14, 2003·Pharmacotherapy·Susan S JickHershel Jick
Sep 16, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Louise Wood, Carlos Martinez
May 11, 2005·Alimentary Pharmacology & Therapeutics·D A ZinkM E Cannon
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Yu-Xiao YangDavid C Metz
May 19, 2007·The American Journal of Gastroenterology·Jennifer LeonardPaul Moayyedi
Jul 31, 2007·Journal of the American Geriatrics Society·Malaz BoustaniHugh Hendrie
Aug 6, 2008·European Journal of Gastroenterology & Hepatology·Evelyn P M van VlietPeter D Siersema
Sep 17, 2008·Annals of Internal Medicine·Monika SarkarYu-Xiao Yang
Mar 11, 2009·Archives of Neurology·Annette L FitzpatrickJosé A Luchsinger
Mar 6, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Nada F KhanPeter W Rose
Oct 27, 2010·Archives of Internal Medicine·Minna RusanenRachel A Whitmer
Feb 15, 2011·Journal of the American Geriatrics Society·Shelly L GrayEric B Larson
Jun 29, 2011·Journal of Alzheimer's Disease : JAD·Neil M DaviesRichard M Martin
Oct 23, 2012·The British Journal of Nutrition·Fiona O'LearySamir Samman
Mar 5, 2013·Journal of Alzheimer's Disease : JAD·Patrick ImfeldChristoph R Meier
Mar 23, 2013·PloS One·Nahuai BadiolaPatrick Aloy
Dec 12, 2013·JAMA : the Journal of the American Medical Association·Jameson R LamDouglas A Corley
Oct 25, 2014·European Archives of Psychiatry and Clinical Neuroscience·Britta HaenischMartin Scherer
Jun 8, 2015·International Journal of Epidemiology·Emily HerrettLiam Smeeth
Jan 9, 2016·International Psychogeriatrics·Anke BookerKarel Kostev
Jan 12, 2016·JAMA Internal Medicine·Benjamin LazarusMorgan E Grams
Mar 24, 2016·Brain, Behavior, and Immunity·Patrick ImfeldChristoph R Meier
May 12, 2016·Circulation Research·Gautham YepuriJohn P Cooke
Jun 8, 2017·Journal of the American Geriatrics Society·Felicia C GoldsteinIhab Hajjar
Jul 12, 2017·The American Journal of Gastroenterology·Heidi TaipaleSirpa Hartikainen
Sep 2, 2017·Therapeutic Advances in Drug Safety·Marina L MaesSunny Anne Linnebur
Nov 15, 2017·Journal of the American Geriatrics Society·Shelly L GrayEric B Larson

❮ Previous
Next ❯

Citations

Feb 5, 2019·British Journal of Pharmacology·Romain BarusRégis Bordet
Jul 25, 2019·Journal of Gastroenterology and Hepatology·Salman HussainAbul Kalam Najmi
Nov 22, 2019·European Journal of Clinical Pharmacology·Yun ZhangYehuan Sun
Dec 6, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Li-Yen TsengFei-Yuan Hsiao
Jun 2, 2020·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Madhav DesaiPrateek Sharma
Oct 7, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Katsuhiro Toda
May 20, 2020·Alzheimer's Research & Therapy·Anna PonjoanRafel Ramos
Aug 8, 2020·Annals of the New York Academy of Sciences·Issac E PerryKenneth J Vega
Nov 14, 2020·International Journal of Environmental Research and Public Health·Liang-Yu ChenChien-An Sun
Feb 17, 2021·BMJ Open Gastroenterology·Peter Fentz HaastrupSanne Rasmussen
May 4, 2021·Journal of Alzheimer's Disease : JAD·Taylor J KrivanekKirk R Daffner
May 21, 2021·European Journal of Clinical Pharmacology·Andrêza Soares Dos SantosRoberta Carvalho Figueiredo
Nov 24, 2021·European Journal of Clinical Pharmacology·Hengmin WangXiaohong Yan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.